Scientific Programmer

Bellwether Bio
Job Location
Seattle, WA 98195
Salary, equity, and benefits commensurate with experience
Job Description

Bellwether Bio, a liquid biopsy technology company, seeks a qualified individual with immediate availability for the position of Scientific Programmer. This full-time position reports to the Chief Technology Officer. The Scientific Programmer will support the CTO to develop Bellwether’s computational toolkit for translating DNA sequencing data into clinically actionable findings, building off of rich and well-curated genomic datasets derived from cohorts of individuals with cancer (or other conditions) and matched controls.

The ideal candidate is a self-motivated, independent, creative programmer with experience the in biological sciences and a passion for improving healthcare outcomes. Expertise with Python, R, C++, and/or other modern scientific programming languages and data visualization packages is required. Experience with analysis of large volumes of data, machine learning, and cloud computing environments is desired.

Specific duties include:

  • Maintenance of and improvements to existing internal-facing software written in Python and R

  • Development and documentation of pipelines for automated and consistent processing of next-generation sequencing (NGS) datasets

  • Analysis of NGS datasets using open-source and/or proprietary tools

  • Visualization of results in the form of figures, tables, and slides


BA, BSc, or equivalent degree required. Substantial coursework and/or professional experience in biology, computer science, statistics, or closely related field strongly preferred. 

How to Apply

To apply, send a CV, brief cover letter, and contact information for three references to Please include “Scientific Programmer” in the subject. The position will remain open until filled. Please be prepared to provide a code sample upon request. 

About Our Organization

Bellwether Bio is a Seattle-based startup developing a novel bioinformatics approach to analyze circulating cell-free DNA. First unveiled in a January 2016 Cell paper, the technology was originally developed in the lab of University of Washington Professor (and HHMI Investigator) Jay Shendure. Bellwether is backed by private investors, and is collaborating with leading diagnostic companies to improve their platforms. We offer compensation (including equity) commensurate with skills and experience, flexible scheduling, and minimal hierarchy. Bellwether Bio does not discriminate on the basis of race, gender, nationality, age, or sexual orientation. All qualified candidates are encouraged to apply.

For more information, please contact:

Matthew Snyder, Ph.D.
Chief Technology Officer 

An analysis appearing in PeerJ finds that social media mentions of a paper may lead to increased citations.

NIH's Michael Lauer looks at the number of grants, their amount, and funding success rates at the agency for last year.

At Nature, Johns Hopkins' Gundula Bosch describes her graduate program that aims to get doctoral students thinking about the big picture.

Patricia Fara writes about childcare funding, and women in science and science history at NPR.